Manuel Beltran (Liquigas) has tested positive for EPO. Testing of his A sample taken July 5th, after the first stage of the Tour de France, indicated the presence of EPO in his system.
Source: L'equipe.fr, Damian Ressiot.
How do you suppose Dorel feels about this given that teams face a €100,000 fine if a link can be established between a rider who returns a positive doping test and his team. Furthermore, Dorel had just renewed their sponsorship agreement with the Liquigas team. What are the potential implications of this positive test with respect to the team's sponsorship?
Already there's the potential that because of this Liquigas may not ride La Vuelta a España.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment